UM

Browse/Search Results:  1-10 of 14 Help

Selected(0)Clear Items/Page:    Sort:
Structure and activity relationship analysis of xanthones from mangosteen: Identifying garcinone E as a potent dual EGFR and VEGFR2 inhibitor Journal article
Li, Jingjing, Nie, Xin, Panthakarn Rangsinth,, Wu, Xiaoping, Zheng, Chengwen, Cheng, Yanfen, Shiu, Polly Ho Ting, Li, Renkai, Lee, Simon Ming Yuen, Fu, Chaomei, Zhang, Jinming, Leung, George Pak Heng. Structure and activity relationship analysis of xanthones from mangosteen: Identifying garcinone E as a potent dual EGFR and VEGFR2 inhibitor[J]. Phytomedicine, 2024, 122, 155140.
Authors:  Li, Jingjing;  Nie, Xin;  Panthakarn Rangsinth,;  Wu, Xiaoping;  Zheng, Chengwen; et al.
Favorite | TC[WOS]:2 TC[Scopus]:3  IF:6.7/6.2 | Submit date:2024/02/22
Epidermal Growth Factor Receptor  Garcinone e  Mangosteen  Vascular Endothelial Growth Factor Receptor 2  Xanthones  
Gαq Is the Specific Mediator of PAR-1 Transactivation of Kinase Receptors in Vascular Smooth Muscle Cells Journal article
Danielle Kamato, Mai Gabr, Hirushi Kumarapperuma, Zheng J. Chia, Wenhua Zheng, Suowen Xu, Narin Osman, Peter J. Little. Gαq Is the Specific Mediator of PAR-1 Transactivation of Kinase Receptors in Vascular Smooth Muscle Cells[J]. International Journal of Molecular Sciences, 2022, 23(22), 14425.
Authors:  Danielle Kamato;  Mai Gabr;  Hirushi Kumarapperuma;  Zheng J. Chia;  Wenhua Zheng; et al.
Favorite | TC[WOS]:2 TC[Scopus]:3 | Submit date:2023/01/31
Epidermal Growth Factor Receptor  Transforming Growth Factor Type i Receptor  Transactivation Dependent  Gpcr  Thrombin  Proteoglycans  
Oriented Layered Graphene Oxide Pad Favoring High Loading Capacity and Stability for High-Throughput Chemical Screening Journal article
Zhou, Mingyue, Li, Yan, Huang, Chuanjin, Wang, Cairen, Liu, Qinghua, Deng, Qibo, Zhang, Huixia, Yin, Tianpeng, Zhu, Guoyuan, Wang, Caiyun, Zhao, Yunfeng, Zhang, Wei. Oriented Layered Graphene Oxide Pad Favoring High Loading Capacity and Stability for High-Throughput Chemical Screening[J]. Advanced Materials Technologies, 2022, 7(9).
Authors:  Zhou, Mingyue;  Li, Yan;  Huang, Chuanjin;  Wang, Cairen;  Liu, Qinghua; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:6.4/8.0 | Submit date:2023/01/30
Comfrey  Epidermal Growth Factor Receptor  Ligand Fishing  Oriented Layered Graphene Oxide Pad  
Disruption of Epidermal Growth Factor Receptor but Not EGF Blocks Follicle Activation in Zebrafish Ovary Journal article
Yanlong Song, Weiting Chen, Bo Zhu, Wei Ge. Disruption of Epidermal Growth Factor Receptor but Not EGF Blocks Follicle Activation in Zebrafish Ovary[J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9, 750888.
Authors:  Yanlong Song;  Weiting Chen;  Bo Zhu;  Wei Ge
Favorite | TC[WOS]:18 TC[Scopus]:19  IF:4.6/5.2 | Submit date:2022/02/21
Epidermal Growth Factor Egf  Egf Receptor Egfr  Gonadal Development  Folliculogenesis  Spermatogenesis  Zebrafish  
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy Journal article
Yuxin Zhao, Haiyong Wang, Chengwei He. Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147(12), 3653-3664.
Authors:  Yuxin Zhao;  Haiyong Wang;  Chengwei He
Favorite | TC[WOS]:20 TC[Scopus]:19  IF:2.7/3.1 | Submit date:2021/12/08
Non-small Cell Lung Cancer  Targeted Therapy  Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor  Drug Resistance  
Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer Journal article
Yang, Zheng, Zhang, Shao-Lin, Hu, Xiaohui, Tam, Kin Yip. Inhibition of pyruvate dehydrogenase kinase 1 enhances the anti-cancer effect of EGFR tyrosine kinase inhibitors in non-small cell lung cancer[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 838, 41-52.
Authors:  Yang, Zheng;  Zhang, Shao-Lin;  Hu, Xiaohui;  Tam, Kin Yip
Favorite | TC[WOS]:27 TC[Scopus]:27  IF:4.2/4.3 | Submit date:2018/10/30
Dichloroacetophenone  Epidermal Growth Factor Receptor  Tyrosine Kinase Inhibitor  Synergism  Hypoxia  Oxidative Phosphorylation  
Autophagic degradation of epidermal growth factor receptor in gefitinib-resistant lung cancer by celastrol Journal article
Xu S.-W., Law B.Y.K., Mok S.W.F., Leung E.L.H., Fan X.X., Coghi P.S., Zeng W., Leung C.-H., Ma D.-L., Liu L., Wong V.K.W.. Autophagic degradation of epidermal growth factor receptor in gefitinib-resistant lung cancer by celastrol[J]. International Journal of Oncology, 2016, 49(4), 1576-1588.
Authors:  Xu S.-W.;  Law B.Y.K.;  Mok S.W.F.;  Leung E.L.H.;  Fan X.X.; et al.
Favorite | TC[WOS]:26 TC[Scopus]:29 | Submit date:2018/11/06
Autophagy  Calcium  Celastrol  Epidermal Growth Factor Receptor  Gefitinib-resistant Lung Cancer  
Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines Journal article
Yang,Zheng, Tam,Kin Y.. Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines[J]. European Journal of Pharmacology, 2016, 789, 458-467.
Authors:  Yang,Zheng;  Tam,Kin Y.
Favorite | TC[WOS]:31 TC[Scopus]:31  IF:4.2/4.3 | Submit date:2021/03/04
Dichloroacetate  Drug Combination  Epidermal Growth Factor Receptor  Erlotinib  Gefitinib  Pyruvate Dehydrogenase Kinase  
Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines Journal article
Yang Z., Tam K.Y.. Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines[J]. European Journal of Pharmacology, 2016, 789, 458-467.
Authors:  Yang Z.;  Tam K.Y.
Favorite | TC[WOS]:31 TC[Scopus]:31 | Submit date:2018/12/18
Dichloroacetate  Drug Combination  Epidermal Growth Factor Receptor  Erlotinib  Gefitinib  Pyruvate Dehydrogenase Kinase  
Prognostic significance of combining VEGFA, FLT1 and KDR mRNA expression in lung cancer Journal article
Zhang S.-D., McCrudden C.M., Kwok H.F.. Prognostic significance of combining VEGFA, FLT1 and KDR mRNA expression in lung cancer[J]. Oncology Letters, 2015, 10(3), 1893-1901.
Authors:  Zhang S.-D.;  McCrudden C.M.;  Kwok H.F.
Favorite | TC[WOS]:20 TC[Scopus]:23 | Submit date:2018/12/19
Angiogenesis  Fms‑related Tyrosine Kinase 1  Kinase Insert Domain Receptor  Lung Cancer  Survival  Vascular Epidermal Growth Factor a